that led to product saturation
and substandard quality,” says
Malay. “With multiple PhDs on
our team, our focus has been
to bring the next generation of
commercial horticultural and
extraction technologies and
meld them with pharmaceuti-
cal acumen for the cannabis
and CBD sector. Now, we are
creating a third-generation
cannabis company focused
on the manufacturing of end-
products for medical patients,
legal adult consumers, and
CBD health and beauty, foods,
edibles, and pet products. Soon
our products will be sold on
retail shelves across Canada,
and parts of Europe, Asia and
the United States.”
Medical and
Adult-use Markets
Using the Canadian market
to pilot and springboard to
international markets, Pure is
creating a strong portfolio of
proprietary products and a
bold brand development strat-
egy for medical and adult-use
markets.
January 2019 was a milestone
month for the company. Its
subsidiary, PureSinse, a phar-
maceutical - grade licensed
producer, received its sales
license under the cannabis
act, allowing eligible and pre-
registered Canadian medical
patients access to premium
4 BUSINESS ELITE CANADA | JUNE 2019
